[1]赵国杰,吴明洪,连海伟,等.中枢神经系统血管母细胞瘤的年龄分层分析[J].中国临床神经外科杂志,2023,28(04):230-233239.[doi:10.13798/j.issn.1009-153X.2023.04.002]
 ZHAO Guo-jie,WU Ming-hong,LIAN Hai-wei,et al.Age-stratified analysis of clinical features and prognoses of patients with central nervous system hemangio-blastomas[J].,2023,28(04):230-233239.[doi:10.13798/j.issn.1009-153X.2023.04.002]
点击复制

中枢神经系统血管母细胞瘤的年龄分层分析()
分享到:

《中国临床神经外科杂志》[ISSN:1009-153X/CN:42-1603/TN]

卷:
28
期数:
2023年04期
页码:
230-233239
栏目:
论著
出版日期:
2023-04-30

文章信息/Info

Title:
Age-stratified analysis of clinical features and prognoses of patients with central nervous system hemangio-blastomas
文章编号:
1009-153X(2023)04-0230-04
作者:
赵国杰吴明洪连海伟刘仁忠
430060武汉,武汉大学人民医院神经外科(赵国杰、吴明洪、连海伟、刘仁忠)
Author(s):
ZHAO Guo-jie WU Ming-hong LIAN Hai-wei LIU Ren-zhong
Department of Neurosurgery, Renmin Hospital of Wuhan University, Wuhan 430060, China
关键词:
中枢神经系统血管母细胞瘤临床特征预后年龄分层分析
Keywords:
Central nervous system hemangioblastoma Clinical feature Prognosis Age Hierarchical analysis
分类号:
A
DOI:
10.13798/j.issn.1009-153X.2023.04.002
文献标志码:
R739.41;R651.1+1
摘要:
目的 探讨不同年龄段的中枢神经系统(CNS)血管母细胞瘤(HB)的临床特征、预后及其影响因素。方法 回顾性分析2016年1月至2022年1月手术治疗的86例CNS-HB的临床资料。根据初次手术年龄分为四个年龄段(≤20岁、21~40岁、41~60岁和≥61岁),分析不同年龄段临床特征、预后差异。结果 CNS-HB以颅内压增高症状为主,其次是小脑症状。肿瘤主要位于幕下,其中小脑占65.6%、脑干占17.7%,其次是脊髓(11.5%),幕上极少(5.2%);实性肿瘤43例(44.8%),囊性肿瘤53例(55.2%)。年龄≤20岁组病程[(1.68±1.87)个月]较年龄≥61岁组[(26.50±50.66)个月]明显缩短(P<0.05)。年龄≤40岁病人VHL病发生率较年龄>40岁病人明显增高(P<0.05)。不同年龄段病人的肿瘤部位、肿瘤性质均无明显差异(P>0.05)。术后41例(42.7%)出现坠积性肺炎,年龄越大,发生肺炎的几率越高(P<0.001)。术后15例(15.6%)出现颅内并发症,实性肿瘤及脑干肿瘤病人术后颅内并发症发生率明显高于囊性肿瘤或肿瘤位于其他部位病人(P<0.05)。末次随访,预后良好78例(81.3%),预后不良8例(18.7%)。多因素logistic回归分析显示男性、肿瘤位于脑干以及实性肿瘤是CNS-HB预后不良的独立危险因素(P<0.001)。结论 年轻HB病人的病程较短,而老年HB病人术后并发症发生率较高,但是年龄不是HB病人预后不良的危险因素,肿瘤部位及肿瘤性质与HB病人不良预后有关。40岁以下病人VHL病发病率较高,建议年轻病人积极进行VHL病的筛查。
Abstract:
Objective To investigate clinical features and risk factors of prognoses of patients with central nervous system (CNS) hemangioblastoma (HB) in different age groups. Methods The clinical data of 86 patients with CNS-HB who underwent surgery from January 2016 to January 2022 were retrospectively analyzed. According to the patients' age at initial operation, all patients were divided into four groups, i.e., ≤20 years, 21~40 years, 41~60 years and ≥61 years groups. The clinical characteristics and prognoses of pateints in different groups were analyzed. Results The main clinical manifestations were intracranial hypertension symptoms. The tumors were mainly located in the infratentorial area, including cerebellum (65.6%) and brain stem (17.7%). There were 43 patients (44.8%) of solid tumors and 53 patients (55.2%) of cystic tumors. The course of disease in ≤20 years group [(1.68±1.87) months] was significantly shorter than that [(26.50±50.66) months] in ≥61 years group (P<0.05). The incidence of VHL disease in patients ≤40 years was significantly higher than that in patients >40 years (P<0.05). There were no significant differences in tumor site and tumor nature among different groups (P>0.05). After surgery, pendulous pneumonia occurred in 41 patients (42.7%), and the older the patient, the higher the risk of pneumonia (P<0.001). Intracranial complications occurred in 15 patients (15.6%) after surgery, and the incidence of intracranial complications was significantly higher in patients with solid tumors than that in patients with cystic tumors (P<0.05), and the incidence of intracranial complications was significantly higher in patients with brain stem tumors than that in patients with tumors locating at the other sites. At the last follow-up, 78 patients (81.3%) had good prognoses, and 8 patients (18.7%) had poor prognoses. Multivariate logistic regression analysis showed that male, tumor locating in the brain stem, and solid tumor were independent risk factors for poor prognoses of patients with CNS-HB (P<0.001). Conclusions Young patients with HB have a shorter course of disease, while elderly patients with HB have a higher incidence of postoperative complications. However, age is not a risk factor for poor prognoses of HB patients, and tumor site and tumor nature are related to poor prognoses of HB patients. The incidence of VHL disease is significantly higher in patients under 40 years, and it is suggested that young HB patients should be actively screened for VHL disease.

参考文献/References:

[1]Kuharic M, Jankovic D, Splavski B, et al. Hemangioblastomas of the posterior cranial fossa in adults: demographics, clinical, morphologic, pathologic, surgical features, and outcomes: a systematic review [J]. World Neurosurg, 2018, 110: e1049-e1062.
[2]Wang H, Zhang L, Wang H, et al. Spinal hemangioblastoma: surgical procedures, outcomes and review of the literature [J]. Acta Neurol Belg, 2021, 121(4): 973-981.
[3]Dornbos D 3rd, Kim HJ, Butman JA, et al. Review of the neurological implications of von Hippel-Lindau disease [J]. JAMA Neurol, 2018, 75(5): 620-627.
[4]Yin X, Duan H, Yi Z, et al. Incidence, prognostic factors and survival for hemangioblastoma of the central nervous system: analysis based on the surveillance, epidemiology, and end results database [J]. Front Oncol, 2020, 10: 570103.
[5]Wang Q, Meng S, Cheng J, et al. Central nervous system hemangioblastomas: an age-stratified analysis [J]. Clin Neurol Neurosurg, 2020, 199: 106281.
[6]龚 侃,王江宜. 中国von Hippel-Lindau病诊治专家共识[J]. 中华医学杂志,2018,98(28):2220-2224.
[7]Wind JJ, Bakhtian KD, Sweet JA, et al. Long-term outcome after resection of brainstem hemangioblastomas in von Hippel-Lindau disease [J]. J Neurosurg, 2011, 114(5): 1312-1318.
[8]Vergauwen E, Steiert C, Kruger MT, et al. Cumulative surgical morbidity in patients with multiple cerebellar and medullary hemangioblastomas [J]. Clin Neurol Neurosurg, 2020, 197: 106111.
[9]Yousef A, Rutkowski MJ, Yalcin CE, et al. Sporadic and von-Hippel Lindau disease-associated spinal hemangioblastomas: institutional experience on their similarities and differences [J]. J Neurooncol, 2019, 143(3): 547-552.
[10]李晓东,马维宁,蒲 柯,等. 中枢神经系统血管母细胞瘤的诊断与治疗:100例报告[J]. 中华神经外科疾病研究杂志,2011,10(6):528-532.
[11]Rachinger J, Buslei R, Prell J, et al. Solid haemangioblastomas of the CNS: a review of 17 consecutive cases [J]. Neurosurg Rev, 2009, 32(1): 37-48.
[12]Aaplie L, Cho YW, Lamano JB, et al. Safety and outcomes of preoperative embolization of intracranial hemangioblastomas: a systematic review [J]. Clin Neurol Neurosurg, 2016, 150: 143-151.

相似文献/References:

[1]刘 琦 郝东宁 周 峰 王 鹏 曾 文 李维新.颈椎前路融合术后相邻节段退变的临床分析[J].中国临床神经外科杂志,2015,(11):665.[doi:10.13798/j.issn.1009-153X.2015.11.008]
 LIU Qi,HAO Dong-ning,ZHOU Feng,et al.Clinical analysis of adjacent segment degeneration after anterior cervical vertebral fusion[J].,2015,(04):665.[doi:10.13798/j.issn.1009-153X.2015.11.008]
[2]刘 征 张新元 伍 杰 王在贵 徐国政.复发胶质瘤恶性进展的回顾性分析[J].中国临床神经外科杂志,2016,(04):230.[doi:10.13798/j.issn.1009-153X.2016.04.012]
[3]娄元华 李小勇 陈红伟 潘栋超 解东成 刘东升.婴儿脑积水分流术后硬膜下积液的临床分析[J].中国临床神经外科杂志,2016,(04):245.[doi:10.13798/j.issn.1009-153X.2016.04.019]
[4]孙成法 姜 华 褚荣涛 金 科.671例慢性硬膜下血肿的临床分析[J].中国临床神经外科杂志,2016,(01):42.[doi:10.13798/j.issn.1009-153X.2016.01.015]
[5]穆林森 张红波 陈谦学 田道锋 徐海涛 李明昌 熊晓星 刘宝辉.原发灶来源不明的脑转移瘤的临床特点及治疗[J].中国临床神经外科杂志,2015,(12):733.[doi:10.13798/j.issn.1009-153X.2015.12.009]
 Mu Lin-sen,ZHANG Hong-bo,CHEN Qian-xue,et al.Clinical features and treatment of brain metastasis in patients with malignant tumors of unknown primary[J].,2015,(04):733.[doi:10.13798/j.issn.1009-153X.2015.12.009]
[6]袁学刚 陈志勇 秦君翔 肖 胜 王 璨 黄锦峰 刘 斌 喻军华.亚急性硬膜下血肿17例临床分析[J].中国临床神经外科杂志,2016,(08):491.[doi:10.13798/j.issn.1009-153X.2016.08.017]
[7]陈福业 丰育功 张丕宁 李环廷 栗世方 郭 品 张洪亮 江俊莹.颅骨海绵状血管瘤20例分析[J].中国临床神经外科杂志,2017,(12):839.[doi:10.13798/j.issn.1009-153X.2017.12.012]
[8]华 刚 谭红平 张立民 杨 琪 郭 强 朱 丹.脑裂头蚴病的诊断和手术治疗体会[J].中国临床神经外科杂志,2018,(03):191.[doi:10.13798/j.issn.1009-153X.2018.03.017]
[9]秦 汉 胡军民 元 玲 秦海林 安学锋 雷 颉.多形性黄色瘤型星形细胞瘤的诊治分析:附7例报道并文献复习[J].中国临床神经外科杂志,2019,(12):721.[doi:10.13798/j.issn.1009-153X.2019.12.001]
 QIN Han,HU Jun-min,YUAN Ling,et al.Diagnosis and treatment of pleomorphic xanthoastrocytomas and review of literature related to them (report of 7 cases)[J].,2019,(04):721.[doi:10.13798/j.issn.1009-153X.2019.12.001]
[10]邹文辉 李俊驹 黄垂学.中枢神经系统类鼻疽病的临床特点分析[J].中国临床神经外科杂志,2020,(03):144.[doi:10.13798/j.issn.1009-153X.2020.03.005]
 ZOU Wen-hui,LI Jun-ju,HUANG Chui-xue..Analysis of clinical characteristics of central nervous system melioidosis (report of 12 cases)[J].,2020,(04):144.[doi:10.13798/j.issn.1009-153X.2020.03.005]

备注/Memo

备注/Memo:
(2022-10-25收稿,2023-02-14修回)
通讯作者:刘仁忠,E-mail:lrz1961@163.com
更新日期/Last Update: 2022-04-30